Lv21
200 积分 2023-09-01 加入
Effectiveness of Vortioxetine in Patients With Major Depressive Disorder in Real-World Clinical Practice: Results of the RELIEVE Study
2小时前
已完结
Perspectives on the impact of vortioxetine on the treatment armamentarium of major depressive disorder
7小时前
已完结
Perioperative sildenafil therapy in pulmonary hypertension associated with congenital cardiac disease: An updated meta-analysis
2个月前
已完结
First add-on lacosamide treatment in children with focal epilepsy in China: A multi-centre real-life cohort study
3个月前
已完结
Comparative Effectiveness and Safety Between Apixaban, Dabigatran, Edoxaban, and Rivaroxaban Among Patients With Atrial Fibrillation
4个月前
已完结
Effect of 15-mg Edoxaban on Clinical Outcomes in 3 Age Strata in Older Patients With Atrial Fibrillation
4个月前
已完结
Comparison of clinical outcomes of edoxaban versus apixaban, dabigatran, rivaroxaban, and vitamin K antagonists in patients with atrial fibrillation in Germany: A real-world cohort study
4个月前
已完结
Venlafaxine, Paroxetine and Milnacipran for Major Depressive Disorder: A Pragmatic 24-Week Study
5个月前
已完结
Prevention of Recurrent Episodes of Depression With Venlafaxine ER in a 1-Year Maintenance Phase From the PREVENT Study
5个月前
已完结
Venlafaxine efficacy and tolerability in the treatment of post-stroke depression
5个月前
已关闭
皖公网安备34019202002308
